PerkinElmer Reports Slightly Better-Than-Expected 4Q Results With EuroImmun Acquisition
PerkinElmer's fourth-quarter results and 2018 outlook were slightly better than we anticipated, with better-than-expected revenue contribution from EuroImmun. We do not anticipate a major change in our fair value estimate after we update our assumptions, and we are reiterating our no-moat rating for now.Although the EuroImmun acquisition enhances the company's autoimmune, allergy, and infectious disease testing capabilities, we remain unconvinced that the company would successfully thwart poten...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.